2021 / 06

Next Paper
DOI: 10.24075/brsmu.2021.061

ORIGINAL RESEARCH

Degenerative disc disease in young adults: cytokine profile and angiogenic factors

Novikova AV1, Pravdyuk NG1, Saklakova VS2, Lolomadze EA2, Feniksov VM3, Nikolaev DA3, Davygora KS1, Timofeev VT1, Shostak NA1
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

3 Pirogov City Clinical Hospital № 1, Moscow, Russia

Correspondence should be addressed: Anna V. Novikova
Ostrovitianova, 1, Moscow, 117997, Russia; ur.liam@8002evonna

About paper

Acknowledgements: we would like to thank neurosurgeons of the Department of Neurosurgery, Nekrasova MA, Babenkova VV, Isaeva AN, Smirnova VA, Glukhova DS, Gabechiya GV, Choriyeva DB, Kozheva AKh, for assistance in our research.

Author contribution: Novikova AV — literature analysis, clinical data acquisition and biomaterial collection, preanalytical phase of the study, data analysis and interpretation, preparation of figures and graphs; Pravdyuk NG — literature analysis, task definition, study design, data analysis and interpretation; Saklakova VS — literature analysis, analytic phase of laboratory testing, definition and statistical analysis of mRNA abundance in biomaterial, scheduling; Lolomadze EA — analysis of laboratory work, analysis of mRNA abundance in biomaterial; Feniksov VМ and Nikolaev DA — admission to clinical data acquisition, neurological examination of patients, discectomy, biomaterial collection; Davygora KS — literature analysis, analysis of laboratory work; Timofeev VT — study planning, preanalytical phase of the study, evaluation of the data obtained; Shostak NA — research management, study design, data interpretation, manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of Pirogov Russian National Research Medical University (protocol № 181 dated January 28, 2019); the informed consent to blood testing and investigation of intervertebral disc was obtained from all participants.

Received: 2021-11-22 Accepted: 2021-12-06 Published online: 2021-12-20
|
  1. Zwierzchowska A, Tuz J. Evaluation of the impact of sagittal spinal curvatures on musculoskeletal disorders in young people. Med Pr. 2018; 69 (1): 29–36. DOI: 10.13075/mp.5893.00558.
  2. Fujii K, Yamazaki M, Kang JD, Risbud MV, Cho SK, Qureshi SA, et al. Discogenic Back Pain: Literature Review of Definition, Diagnosis, and Treatment JBMR Plus. 2019; 3 (5): e10180. DOI: 10.1002/jbm4.10180.
  3. Anitua E, Padilla S. Biologic therapies to enhance intervertebral disc repair. RegenMed. 2018; 13 (1): 55–72. DOI: 10.2217/rme2017-0111.
  4. Hu S, Fu Y, Yan B, Shen Z, Lan T. Analysis of key genes and pathways associated with the pathogenesis of intervertebral disc degeneration. J Orthop Surg Res. 2020; 15 (1): 371. DOI: 10.1186/s13018-020-01902-4.
  5. Li Y, Liu J, Liu Z, Duan D. Inflammation in low back pain may be detected from the peripheral blood: suggestions for biomarker. Biosci Rep. 2016; 36 (4): e00361. DOI: 10.1042/BSR20160187.
  6. Hodgkinson T, Shen B, Diwan A, Hoyland JA, Richardson SM. Therapeutic potential of growth differentiation factors in the treatment of degenerative disc diseases. Spine. 2019; 2 (1): e1045. DOI: 10.1002/jsp2.1045.
  7. Kraychete DC, Sakata RK, Issy AM, Bacellar O, Santos-Jesus R, Carvalho EM. Serum cytokine levels in patients with chronic low back pain due to herniated disc: analytical cross-sectional study. Sao Paulo Med J. 2010; 128 (5): 259–62. DOI: 10.1590/s151631802010000500003.
  8. Studer RK, Vo N, Sowa G, Ondeck C, Kang J. Human nucleus pulposus cells react to IL6: independent actions and amplification of response to IL1 and TNFα. Spine. 36: 593–9. DOI: 10.1097/ BRS.0b013e3181da38d5
  9. Gabr MA, Jing L, Helbling AR, Sinclair SM, Allen KD, Shamji MF, et al. Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res. 2011; 29 (1): 1–7. DOI: 10.1002/jor.21206.
  10. Rodrigues LMR, Oliveira LZ, Silva MBRD, Accardo CM, Giglio ABD, Pinhal MADS. Inflammatory biomarkers in sera of patients with intervertebral disc degeneration. Einstein (Sao Paulo). 2019; 17 (4): eAO4637. DOI: 10.31744/einstein_journal/2019AO4637.
  11. Baptista JS, Traynelis VC, Liberti EA, Fontes RBV. Expression of degenerative markers in intervertebral discs of young and elderly asymptomatic individuals. PLoS One. 2020; 15 (1): e0228155. DOI: 10.1371/journal.pone.0228155.
  12. Capossela S, Bertolo A, Gunasekera K, Pötzel T, Baur M, Stoyanov JV. VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process. BMC Res Notes. 2018; 11: 333 DOI: 10.1186/s13104-018-3441-3.
  13. Haro H, Kato T, Komori H, Osada M, Shinomiya K. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res. 2002; 20 (3): 409–15. DOI: 10.1016/S0736-0266(01)00150-4
  14. Autio RA, Karppinen J, Niinimäki J, Ojala R, Kurunlahti M, Haapea M, et al. Determinants of spontaneous resorption of intervertebral disc herniations. Spine. 2006; 31 (11): 1247–52. DOI: 10.1097/01. brs.0000217681.83524.4a.
  15. Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Rating scales for low back pain. Br Med Bull. 2010; 94: 81–144. DOI: 10.1093/bmb/ldp052.
  16. Farasyn A, Meeusen R. Validity of the new Backache Index (BAI) in patients with low back pain. Spine J. 2006; 6 (5): 565–71. DOI: 10.1016/j.spinee.2006.01.021.
  17. Rebrikov DV, Samatov GA, Trofimov DYu. PCR v real'nom vremeni. M.: Laboratorija znanij, 2019; 216s.
  18. Andrade P, Visser-Vandewalle V, Philippens M, Daemen MA, Steinbusch HWM, Buurman WA, et al. TNF-alpha levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between TNF receptor 1 and 2. Pain. 2011; 152: 2645–52. DOI: 10.1016/j.pain.2011.08.012.
  19. Altun I. Cytokine profile in degenerated painful intervertebral disc: variability with respect to duration of symptoms and type of disease. Spine J. 2016; 16 (7): 857–61. DOI: 10.1016/j.spinee.2016.03.019.
  20. Kang R, Li H, Rickers K, Ringgaard S, Xie L, Bünger C. Intervertebral disc degenerative changes after intradiscal injection of TNFα in a porcine model. Eur Spine J. 2015; 24 (9): 2010–6. DOI: 10.1007/s00586-015-3926-x.
  21. Wang S, Wei J, Fan Y, Ding H, Tian H, Zhou X, et al. Progranulin Is Positively Associated with Intervertebral Disc Degeneration by Interaction with IL10 and IL17 Through TNF Pathways. Inflammation. 2018; 41 (5): 1852–63. DOI: 10.1007/s10753-0180828-1.
  22. Wang SS, Zhang W, Zhang YQ, Zhao Y, Liu Y, Li JK, et al. IL17A enhances ADAMTS-7 expression through regulation of TNFα in human nucleus pulposus cells. J Mol Histol. 2015; 46 (6): 475–83. DOI: 10.1007/s10735-015-9640-5.
  23. Ohba T, Haro H, Ando T, Wako M, Suenaga F, Aso Y, et al. TNFalpha-induced NF-kappaB signaling reverses age-related declines in VEGF induction and angiogenic activity in intervertebral disc tissues. J Orthop Res. 2009; 27 (2): 229–35. DOI: 10.1002/ jor.20727.
  24. Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, et al. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 2014; 16 (5): 416. DOI: 10.1186/s13075-0140416-1.
  25. Zhang JF, Wang GL, Zhou ZJ, Fang XQ, Chen S, Fan SW. Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Interleukins in Vertebral Cartilage Endplate. Orthop Surg. 2018; 10 (4): 306–11. DOI: 10.1111/os.12409.
  26. Oh CH, Yoon SH. Whole Spine Disc Degeneration Survey according to the Ages and Sex Using Pfirrmann Disc Degeneration Grades. Korean J Spine. 2017; 14 (4): 148–54. DOI: 10.14245/ kjs.2017.14.4.148.
  27. Akyol S, Eraslan BS, Etyemez H, Tanriverdi T, Hanci M. Catabolic cytokine expressions in patients with degenerative disc disease. Turk Neurosurg. 2010; 20 (4): 492–9. DOI: 10.5137/1019-5149. JTN.3394-10.1.
  28. Takeno K, Kobayashi S, Negoro K, Uchida K, Miyazaki T, Yayama T, et al. Physical limitations to tissue engineering of intervertebral disc cells: effect of extracellular osmotic change on glycosaminoglycan production and cell metabolism. Laboratory investigation. J Neurosurg Spine. 2007; 7 (6): 637–44. DOI: 10.3171/SPI-07/12/637.
  29. Chung SA, Khan SN, Diwan AD. The molecular basis of intervertebral disk degeneration. Orthop Clin North Am. 2003; 34 (2): 209–19. DOI: 10.1016/s0030-5898(03)00026-9.